Stock listing
TPEx:6734 iXensor Co., Ltd. (安盛生) 股價
Follow iXensor Co., Ltd. into a list and get an email when it puts out news.
Share price · TPEX:6734
$4.71 TWD -0.29 (-5.8%)
Close on Nov 20, 2026
- Day range
- $4.64 – $4.98 TWDNov 20, 2026
- Volume
- 59,017 sharesNov 20, 2026
- Market cap
- $198.1M TWDAt the close on Nov 20, 2026 · price × 42.05M shares outstanding
- 52-week range
- $4.18 – $18.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $714,439 TWDMedian day 51,779 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6734 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.71 | -0.29 | -5.8% | $4.84 | $4.98 | $4.64 | 59,017 | |
| $5.00 | 0.00 | 0.0% | $5.00 | $5.26 | $4.71 | 56,251 | |
| $5.00 | -0.26 | -4.9% | $5.10 | $5.20 | $4.94 | 47,402 | |
| $5.26 | -0.04 | -0.8% | $5.15 | $5.39 | $5.09 | 50,111 | |
| $5.30 | +0.12 | +2.3% | $5.39 | $5.39 | $5.13 | 34,102 | |
| $5.18 | -0.12 | -2.3% | $5.30 | $5.40 | $5.13 | 81,689 | |
| $5.30 | +0.20 | +3.9% | $5.10 | $5.30 | $5.05 | 35,573 | |
| $5.10 | -0.10 | -1.9% | $5.26 | $5.47 | $5.10 | 64,935 | |
| $5.20 | -0.05 | -1.0% | $5.13 | $5.40 | $5.00 | 67,001 | |
| $5.25 | -0.12 | -2.2% | $4.99 | $5.47 | $4.18 | 354,409 | |
| $5.37 | +0.17 | +3.3% | $5.20 | $5.47 | $5.11 | 93,135 | |
| $5.20 | +0.01 | +0.2% | $5.19 | $5.26 | $4.94 | 40,170 | |
| $5.19 | -0.08 | -1.5% | $5.27 | $5.36 | $4.95 | 55,530 | |
| $5.27 | +0.07 | +1.3% | $5.25 | $5.27 | $5.02 | 8,140 | |
| $5.20 | 0.00 | 0.0% | $5.13 | $5.20 | $4.78 | 148,175 | |
| $5.20 | -0.20 | -3.7% | $5.40 | $5.42 | $5.15 | 28,742 | |
| $5.40 | 0.00 | 0.0% | $5.15 | $5.41 | $5.13 | 37,264 | |
| $5.40 | -0.45 | -7.7% | $5.85 | $5.89 | $5.25 | 210,007 | |
| $5.85 | 0.00 | 0.0% | $5.85 | $5.85 | $5.85 | 0 | |
| $5.85 | +0.74 | +14.5% | $5.29 | $6.10 | $5.29 | 269,501 | |
| $5.11 | -0.09 | -1.7% | $5.20 | $5.30 | $4.96 | 25,858 | |
| $5.20 | 0.00 | 0.0% | $5.20 | $5.20 | $4.95 | 33,470 | |
| $5.20 | 0.00 | 0.0% | $5.20 | $5.20 | $4.95 | 13,047 | |
| $5.20 | -0.04 | -0.8% | $5.24 | $5.25 | $4.95 | 30,238 | |
| $5.24 | -0.18 | -3.3% | $5.16 | $5.42 | $4.98 | 50,792 | |
| $5.42 | +0.22 | +4.2% | $5.40 | $5.45 | $5.16 | 26,671 | |
| $5.20 | +0.11 | +2.2% | $5.26 | $5.47 | $5.15 | 43,365 | |
| $5.09 | -0.51 | -9.1% | $5.60 | $5.61 | $5.09 | 73,658 | |
| $5.60 | +0.297 | +5.6% | $5.37 | $5.78 | $5.22 | 133,680 | |
| $5.303 | +0.03 | +0.6% | $5.283 | $5.303 | $5.046 | 4,245 | |
| $5.273 | +0.188 | +3.7% | $4.987 | $5.273 | $4.977 | 52,765 | |
| $5.086 | -0.395 | -7.2% | $5.481 | $5.629 | $4.701 | 186,606 | |
| $5.481 | +0.471 | +9.4% | $5.194 | $5.728 | $4.987 | 70,940 | |
| $5.01 | -0.04 | -0.8% | $5.26 | $5.26 | $5.01 | 42,941 | |
| $5.05 | -0.26 | -4.9% | $5.31 | $5.31 | $4.95 | 79,295 | |
| $5.31 | +0.15 | +2.9% | $5.16 | $5.36 | $5.06 | 37,501 | |
| $5.16 | -0.04 | -0.8% | $5.20 | $5.47 | $5.16 | 49,373 | |
| $5.20 | +0.15 | +3.0% | $5.25 | $5.56 | $5.20 | 37,577 | |
| $5.05 | -0.27 | -5.1% | $5.30 | $5.54 | $5.05 | 82,412 | |
| $5.32 | -0.30 | -5.3% | $5.62 | $5.62 | $5.30 | 54,254 | |
| $5.62 | +0.02 | +0.4% | $5.51 | $5.70 | $5.30 | 121,884 | |
| $5.60 | -0.09 | -1.6% | $5.66 | $5.70 | $5.50 | 89,754 | |
| $5.69 | -0.23 | -3.9% | $5.92 | $5.92 | $5.43 | 135,829 | |
| $5.92 | -0.58 | -8.9% | $6.41 | $6.69 | $5.61 | 326,675 | |
| $6.50 | -0.98 | -13.1% | $7.18 | $7.61 | $6.38 | 554,279 | |
| $7.48 | +1.38 | +22.6% | $6.14 | $7.90 | $5.70 | 1,668,254 | |
| $6.10 | +1.08 | +21.5% | $4.99 | $6.23 | $4.98 | 701,153 | |
| $5.02 | -0.23 | -4.4% | $5.10 | $5.26 | $4.99 | 46,178 | |
| $5.25 | -0.25 | -4.5% | $5.32 | $5.54 | $4.95 | 114,993 | |
| $5.50 | -0.10 | -1.8% | $5.75 | $5.75 | $5.30 | 37,454 | |
| $5.60 | -0.02 | -0.4% | $5.90 | $5.90 | $5.35 | 226,584 | |
| $5.62 | -0.37 | -6.2% | $6.10 | $6.10 | $5.62 | 38,602 | |
| $5.99 | -0.06 | -1.0% | $5.76 | $6.26 | $5.61 | 64,049 | |
| $6.05 | +0.06 | +1.0% | $5.99 | $6.24 | $5.76 | 101,823 | |
| $5.99 | -0.06 | -1.0% | $6.10 | $6.10 | $5.99 | 26,714 | |
| $6.05 | -0.25 | -4.0% | $6.30 | $6.31 | $5.99 | 22,328 | |
| $6.30 | +0.10 | +1.6% | $6.20 | $6.31 | $5.90 | 59,535 | |
| $6.20 | -0.20 | -3.1% | $6.10 | $6.20 | $5.90 | 28,821 | |
| $6.40 | -0.09 | -1.4% | $6.10 | $6.40 | $6.10 | 10,020 | |
| $6.49 | -0.13 | -2.0% | $6.62 | $6.62 | $6.29 | 10,232 | |
| $6.62 | +0.21 | +3.3% | $6.13 | $6.63 | $6.13 | 45,173 | |
| $6.41 | +0.03 | +0.5% | $6.08 | $6.41 | $6.08 | 11,448 |
Splits
1 split · TPEX:6734 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-5 | Consolidation |
- Ticker
- TPEx:6734
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TPEx
- Currency
- TWD
iXensor Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales 6.9× against a median of 1.5×: 9th lowest of 10 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $185.5M TWD
- P/E
- Loss
- EV/sales
- 6.9×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 23.1×
- Gross margin
- 62.9%
- Operating margin
- −170.1%
- Net margin
- −174.7%
- Debt to equity
- 0.9×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| iXensor Co., Ltd. · TPEX:6734 | US$6.01M | US$5.63M | n/a | 6.9× | n/a | 23.1× | −174.7% | 0.9× | n/a |
| Fusion Antibodies PLC · LSE:FAB | US$6.96M | US$6.03M | n/a | 2.2× | n/a | 3.3× | −54.4% | 0.2× | n/a |
| IDL Diagnostics AB · OMXSTO:IDLDX | US$6.83M | US$4.56M | 4.6× | 0.8× | n/a | 0.5× | 25.8% | 0.1× | n/a |
| Visgeneer, Inc. · TPEX:4197 | US$6.55M | US$7.99M | 41.1× | 1.5× | 36.6× | 1.1× | 2.9% | 0.5× | n/a |
| Milton Essex S.A. · NEWCONNECT:MTN | US$6.07M | US$6.06M | n/a | 17,573× | n/a | 0.5× | n/a | 0.0× | n/a |
| Cizzle Biotechnology Holdings PLC · LSE:CIZ | US$5.70M | US$5.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| AcouSort AB · OMXSTO:ACOU | US$5.69M | US$4.76M | n/a | 6.1× | n/a | 5.9× | −140.8% | 0.0× | n/a |
| GENinCode PLC · LSE:GENI | US$5.42M | US$2.86M | n/a | 0.7× | n/a | 2.0× | −185.5% | 0.1× | n/a |
| Nanologica AB · OMXSTO:NICA | US$5.29M | US$8.67M | 2.9× | 1.6× | n/a | 0.3× | 34.9% | 0.3× | n/a |
| VivoSim Labs, Inc. · NASDAQ:VIVS | US$5.29M | −US$2.76M | n/a | −20.5× | n/a | 0.7× | n/a | 0.1× | 1.91 |
| Biomerica, Inc. · NASDAQ:BMRA | US$4.97M | US$2.23M | n/a | 0.5× | n/a | 1.4× | −115.5% | 0.0× | 0.71 |
| Median of the others | US$5.70M | US$5.18M | 4.6× | 1.5× | 36.6× | 1.1× | −54.4% | 0.1× | 1.31 |
Team and board
Officers
| Officer | Role |
|---|---|
| Carson Chen | Chairman & CEO |
| Peter Fitzgerald | Director & Chief Medical Advisor |
Board
| Director | Role |
|---|---|
| Carson Chen | Chairman & CEO |
| Peter Fitzgerald | Director & Chief Medical Advisor |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 26.9M | 19.5M | 20.9M | 105.2M | 24.8M | 15.9M | 30.0M |
| Cost of revenue | 9.98M | 13.5M | 19.3M | 42.6M | 20.2M | 11.4M | 21.0M |
| Gross profit | 16.9M | 6.00M | 1.60M | 62.6M | 4.62M | 4.50M | 9.03M |
| Research and development | 27.2M | 26.0M | 26.2M | 28.0M | 47.1M | 36.1M | 42.4M |
| Selling, general and administrative | 35.4M | 14.5M | 19.4M | 17.6M | 19.3M | 24.3M | 41.1M |
| Operating income | -45.7M | -46.1M | -63.0M | -5.23M | -81.5M | -80.0M | -109.0M |
| Depreciation and amortization | 6.00M | 6.17M | 5.95M | 7.13M | 8.70M | 10.9M | 11.9M |
| EBITDA | -39.7M | -39.9M | -57.1M | 1.90M | -72.8M | -69.1M | -97.1M |
| Interest expense | 1.33M | 1.32M | 492.0K | 150.0K | 48.0K | 127.0K | 177.0K |
| Income before tax | -47.0M | -46.8M | -63.2M | -4.89M | -73.1M | -76.6M | -104.7M |
| Net income | -47.0M | -46.8M | -63.2M | -4.89M | -73.1M | -76.6M | -104.7M |
| Earnings per share, basic | -1.16 | -2.05 | -1.15 | -0.09 | -1.40 | -1.55 | -2.15 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 38.3M | 37.1M | 47.4M | 46.2M | 13.8M | 34.8M | 66.3M |
| Short-term investments | 2.28M | 1.90M | 1.57M | 1.60M | 1.60M | 5.90M | 30.6M |
| Receivables | 190.0K | 1.59M | 2.28M | 1.87M | 6.63M | 3.47M | 8.10M |
| Inventory | 9.01M | 9.55M | 12.2M | 20.2M | 26.6M | 18.4M | 25.0M |
| Current assets | 54.6M | 53.9M | 69.3M | 75.7M | 56.7M | 69.1M | 142.1M |
| Total assets | 69.0M | 74.6M | 96.4M | 104.7M | 73.6M | 97.5M | 179.3M |
| Accounts payable | 2.20M | 321.0K | 939.0K | 585.0K | 839.0K | 242.0K | 179.0K |
| Current liabilities | 34.2M | 25.5M | 38.7M | 11.2M | 16.6M | 16.8M | 19.8M |
| Long-term debt | 10.1M | 12.9M | 15.8M | 0 | |||
| Total debt | 58.9M | 52.5M | 16.7M | 1.67M | 6.16M | 10.7M | |
| Total liabilities | 45.9M | 64.6M | 63.6M | 24.0M | 16.6M | 18.4M | 25.8M |
| Shareholders' equity | 23.1M | 10.1M | 32.7M | 80.7M | 57.0M | 79.1M | 153.5M |
| Shares outstanding | 40.6M | 22.8M | 54.9M | 54.2M | 52.3M | 49.3M | 48.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -36.9M | -40.3M | -46.2M | 8.12M | -72.0M | -57.2M | -97.0M |
| Capital spending | -378.0K | -1.07M | -1.75M | -745.0K | -1.58M | -1.85M | -1.54M |
| Free cash flow | -37.3M | -40.9M | -47.9M | 7.37M | -73.5M | -59.0M | -98.5M |
| Cash from investing | -1.68M | -2.93M | -680.0K | 4.26M | 28.1M | 46.2M | |
| Cash from financing | 31.7M | 50.3M | 24.9M | 46.6M | -2.42M | 11.0M | |
| Change in cash | 1.15M | -10.3M | 1.20M | 32.4M | -21.1M | -31.4M | -39.7M |
Cap table
Built by 6ix from iXensor Co., Ltd.’s releases
- Common shares
- 42,051,552
- Fully diluted
- 42,051,552
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 42,051,552 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 42,051,552 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carson Chen | Chairman & CEO · Since at least Nov 5, 2026 |
| Peter Fitzgerald | Director & Chief Medical Advisor · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about iXensor Co., Ltd.